Advertisement

Ads Placeholder
Loading...

Haleon plc

HLN•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$9.93
$-0.04(-0.40%)
U.S. Market opens in 0h 27m

Haleon plc (HLN) Stock Overview

Explore Haleon plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap44.3B
P/E Ratio12.05
EPS (TTM)$0.49
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$9.61
3 Months$12.21
1 Year Target$10.77

HLN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haleon plc (HLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.00, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.05 and a market capitalization of 44.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.40%
5-Day Change
1.43%
1-Month Change
-6.41%
3-Month Change
-0.70%
6-Month Change
10.95%
Year-to-Date (YTD) Change
-0.70%
1-Year Change
-4.98%
3-Year Change
21.54%
5-Year Change
32.40%
All-Time (Max) Change
32.40%

Contact Information

https://www.haleon.com
44 1932 822000
Building 5, Weybridge, NaN, KT13 0NY

Company Facts

245,610 Employees
IPO DateJul 25, 2022
CountryGB
Actively Trading

Frequently Asked Questions